vs
Side-by-side financial comparison of GERON CORP (GERN) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.
GERON CORP is the larger business by last-quarter revenue ($47.2M vs $38.5M, roughly 1.2× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs -39.0%, a 307.7% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs 67.1%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 301.6%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
GERN vs ORC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $38.5M |
| Net Profit | $-18.4M | $103.4M |
| Gross Margin | — | — |
| Operating Margin | -29.4% | — |
| Net Margin | -39.0% | 268.7% |
| Revenue YoY | 67.1% | 372.6% |
| Net Profit YoY | 30.3% | 1764.9% |
| EPS (diluted) | $-0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $38.5M | ||
| Q3 25 | $47.2M | $26.9M | ||
| Q2 25 | $49.0M | $23.2M | ||
| Q1 25 | $39.6M | $19.7M | ||
| Q3 24 | $28.3M | $340.0K | ||
| Q2 24 | $882.0K | $-697.0K | ||
| Q1 24 | $304.0K | $-2.5M | ||
| Q4 23 | $23.0K | — |
| Q4 25 | — | $103.4M | ||
| Q3 25 | $-18.4M | $72.1M | ||
| Q2 25 | $-16.4M | $-33.6M | ||
| Q1 25 | $-19.8M | $17.1M | ||
| Q3 24 | $-26.4M | $17.3M | ||
| Q2 24 | $-67.4M | $-5.0M | ||
| Q1 24 | $-55.4M | $19.8M | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -29.4% | — | ||
| Q2 25 | -25.4% | — | ||
| Q1 25 | -42.2% | — | ||
| Q3 24 | -99.8% | — | ||
| Q2 24 | -7860.9% | — | ||
| Q1 24 | -18465.1% | — | ||
| Q4 23 | — | — |
| Q4 25 | — | 268.7% | ||
| Q3 25 | -39.0% | 267.8% | ||
| Q2 25 | -33.4% | -145.0% | ||
| Q1 25 | -50.1% | 86.9% | ||
| Q3 24 | -93.5% | 5094.1% | ||
| Q2 24 | -7639.8% | 714.3% | ||
| Q1 24 | -18220.4% | -794.2% | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.02 | — | ||
| Q1 25 | $-0.03 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.10 | — | ||
| Q1 24 | $-0.09 | — | ||
| Q4 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $665.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | $1.4B |
| Total Assets | $567.4M | $11.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $665.9M | ||
| Q3 25 | $78.1M | $583.9M | ||
| Q2 25 | $77.7M | $440.8M | ||
| Q1 25 | $83.7M | $396.4M | ||
| Q3 24 | $60.3M | $322.1M | ||
| Q2 24 | $116.9M | $241.0M | ||
| Q1 24 | $189.8M | $190.4M | ||
| Q4 23 | $70.0M | — |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $248.7M | $1.1B | ||
| Q2 25 | $259.5M | $912.0M | ||
| Q1 25 | $268.2M | $855.9M | ||
| Q3 24 | $292.3M | $656.0M | ||
| Q2 24 | $306.7M | $555.9M | ||
| Q1 24 | $344.9M | $481.6M | ||
| Q4 23 | $247.9M | — |
| Q4 25 | — | $11.7B | ||
| Q3 25 | $567.4M | $9.1B | ||
| Q2 25 | $555.2M | $7.6B | ||
| Q1 25 | $562.5M | $7.3B | ||
| Q3 24 | $444.9M | $5.9B | ||
| Q2 24 | $449.4M | $4.9B | ||
| Q1 24 | $482.1M | $4.2B | ||
| Q4 23 | $394.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $120.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.16× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $120.4M | ||
| Q3 25 | $-13.6M | $28.0M | ||
| Q2 25 | $-27.4M | $18.4M | ||
| Q1 25 | $-48.0M | $25.8M | ||
| Q3 24 | $-58.9M | $-14.8M | ||
| Q2 24 | $-53.5M | $19.3M | ||
| Q1 24 | $-62.3M | $45.0M | ||
| Q4 23 | $-167.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-53.7M | — | ||
| Q1 24 | $-62.9M | — | ||
| Q4 23 | $-168.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6086.6% | — | ||
| Q1 24 | -20680.3% | — | ||
| Q4 23 | -732926.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 202.3% | — | ||
| Q4 23 | 3608.7% | — |
| Q4 25 | — | 1.16× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.51× | ||
| Q3 24 | — | -0.86× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.28× | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
